Genetic and protein changes of E-cadherin in meningiomas

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 5, 2010, Pages 695-702

  Pećina Šlaus, Nives ^a   Martić, Tamara Nikuševa ^a   Deak, Adam Jakov ^a   Zeljko, Martina ^a   Hrašćan, Reno ^b   Tomas, Davor ^c   Musani, Vesna ^d  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^d RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

CDH1; E cadherin; Immunostaining; Loss of heterozygosity; Meningiomas; Replication error

Indexed keywords

BETA CATENIN; UVOMORULIN; WNT PROTEIN; CADHERIN;

ADULT; AGED; ANGIOMA; ARTICLE; CANCER GENETICS; CANCER GRADING; CELL JUNCTION; CELL NUCLEUS; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; FIBROMA; GENE IDENTIFICATION; GENE REPLICATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR SUPPRESSOR GENE; UPREGULATION; GENETICS; GENOMIC INSTABILITY; METABOLISM; MIDDLE AGED;

ADULT; AGED; BETA CATENIN; CADHERINS; FEMALE; GENOMIC INSTABILITY; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED;

EID: 77950489461     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0708-z     Document Type: Article

References (29)

1. Akat K, Bleck CK, Lee YM et al (2008) Characterization of a novel type of adherens junction in meningiomas and the derived cell line HBL-52. Cell Tissue Res 331:401-412
2. Brunner EC, Romeike BF, Jung M et al (2006) Altered expression of beta-catenin/E-cadherin in meningiomas. Histopathology 49:178-187
3. Ellison DW, Onilude OE, Lindsey JC, United Kingdom Children's Cancer Study Group Brain Tumour Committee et al (2005) Betacatenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee. J Clin Oncol 23:7951-7957
4. Fogarty MP, Kessler JD, Wechsler-Reya RJ (2005) Morphing into cancer: the role of developmental signaling pathways in brain tumor formation. J Neurobiol 64:458-475
5. Fuller CE, Perry A (2005) Molecular diagnostics in central nervous system tumors. Adv Anat Pathol 12:180-194
6. Gordon MD, Nusse R (2006) Wnt signalling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281:22429-22433
7. Hall AC, Lucas FR, Salinas PC (2000) Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT- 7a signaling. Cell 100:525-535
8. Howng SL, Wu CH, Cheng TS et al (2002) Differential expression of Wnt genes, beta-catenin and E-cadherin in human brain tumors. Cancer Lett 183:95-101
9. Ionov Y, Peinado MA, Malkhosyan S et al (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558-561
10. Kleihues P, Louis DN, Scheithauer BW et al (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225
11. Koch A, Waha A, Tonn JC et al (2001) Somatic mutations of WNT/ wingless signaling pathway components in primitive neuroectodermal tumors. Int J Cancer 93:445-449
12. Li F, Chong ZZ, Maiese K (2006) Winding through the WNT pathway during cellular development and demise. Histol Histopathol 21:103-124
13. Lie DC, Colamarino SA, Song HJ et al (2005) Wnt signaling regulates adult hippocampal neurogenesis. Nature 437:1370-1375
14. Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109
15. Nagashima G, Fujimoto T, Suzuki R et al (2006) Dural invasion of meningioma: a histological and immunohistochemical study. Brain Tumor Pathol 23:13-17
16. Panagopoulos AT, Lancellotti CL, Veiga JC et al (2008) Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas. J Neurooncol 89:73-87
17. Patapoutian A, Reichardt LF (2000) Roles of wnt proteins in neural development maintenance. Curr Opin Neurobiol 10:392-399
18. Pećina-Šlaus N (2003) Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int E3:17. http://www.cancerci.com/content/3/1/17
19. Pećina-Šlaus N, Gall-Trošelj K, Kapitanović S et al (2002) Novel alleles of the D16S752 polymorphic genetic marker linked to Ecadherin gene: a potential population marker. Coll Antropol 26:85-88
20. Pećina-Šlaus N, Nikuševa Martić T, Tomas D et al (2008) Meningiomas exhibit loss of heterozygosity of the APC gene. J Neurooncol 87:63-70
21. Perry A, Gutmann DH, Reifenberger G (2004) Molecular pathogenesis of meningiomas. J Neurooncol 70:183-202
22. Polakis P (2007) The many ways of Wnt in cancer. Curr Opin Genet Dev 17:45-51
23. Riemenschneider MJ, Perry A, Reifenberger G (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5:1045-1054
24. Schwechheimer K, Zhou L, Birchmeier W (1998) E-cadherin in human brain tumours: loss of immunoreactivity in malignant meningiomas. Virchows Arch 432:163-167
25. Shimamura K, Takeichi M (1992) Local and transient expression of E-cadherin involved in mouse embryonic brain morphogenesis. Development 116:1011-1019
26. Utsuki S, Oka H, Sato Y et al (2005) Invasive meningioma is associated with a low expression of E-cadherin and beta-catenin. Clin Neuropathol 24:8-12
27. Weber RG, Bostrom J, Wolter M et al (1997) Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94:14719-14724
28. Wrobel G, Roerig P, Kokocinski F et al (2005) Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identified novel genes associated with meningioma progression. Int J Cancer 114:249-256
29. Yu X, Malenka RC (2003) Beta-catenin is critical for dendritic morphogenesis. Nat Neurosci 6:1169-1177